elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37244781-5318E819-DF3D-4367-9CBA-E0D623F63E17
Q37244781-5318E819-DF3D-4367-9CBA-E0D623F63E17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37244781-5318E819-DF3D-4367-9CBA-E0D623F63E17
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.
P2860
Q37244781-5318E819-DF3D-4367-9CBA-E0D623F63E17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37244781-5318E819-DF3D-4367-9CBA-E0D623F63E17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7b60da17ee809c4f0b0c68f7035afd7da462a45
P2860
Anti-VEGF therapy: comparison of current and future agents.